• Harvey Norman vs Premier Investments: Which founder-led stock is the better buy in 2026?

    CEO leading a board meeting.

    Harvey Norman vs Premier Investments shares

    Deciding between Harvey Norman Holdings Ltd (ASX: HVN) and Premier Investments Ltd (ASX: PMV) promises an interesting founder-led face-off. Both companies are household names in Australian retail, but each brings its own strengths, quirks, and opportunities. If you’re weighing up Harvey Norman vs Premier Investments shares for your 2026 watchlist, here’s a simple, no-nonsense look at which might suit you best.

    The case for Harvey Norman

    Harvey Norman is a stalwart of the Australian retail landscape, famous for its big-box stores selling everything from electronics and computers to furniture and homewares. As the franchisor behind more than 270 company-operated and franchised outlets in eight countries—including Australia, New Zealand, Singapore, and Ireland—Harvey Norman has built scale and a significant property portfolio over decades. Much of its earnings still come from Australia, but its international arm is growing in significance.

    Looking at fundamentals:

    • Market cap sits at $5.15 billion, marking it as a major ASX player.
    • A P/E ratio of 9.80 suggests investors are paying less per dollar of reported earnings than for Premier, although sector differences should be kept in mind.
    • Dividend yield of 6.63%, fully franked, has been consistently healthy with recent final and interim payouts of $0.13 and $0.145 per share respectively in 2026.

    Harvey Norman’s founder, Gerry Harvey, still guides the business, providing the kind of continuity some investors look for in retail. Its extensive history of property ownership also underlines its blend of retail and real asset exposure.

    The case for Premier Investments

    Premier Investments recently reshaped itself after demerging its apparel brands (like Just Jeans and Portmans) into Myer Holdings. Now it’s focused on two growth engines: Peter Alexander, which dominates sleepwear and lifestyle retail, and Smiggle, a favourite among school-aged kids for its playful stationery and backpack range. Both brands are expanding internationally, especially Smiggle in the UK and Asia. Premier also keeps a significant stake in Myer, giving it continued exposure to broader Australian retail.

    Key numbers for Premier:

    • It’s smaller than Harvey Norman by market cap, at $1.98 billion, but packs a punch in yield and earnings.
    • P/E ratio of 15.38, a notable premium, could reflect its stronger growth story or the market’s confidence post-demerger.
    • Dividend yield is impressive at 7.67%, fully franked, and the 2026 interim payout was $0.45 per share, with past years featuring additional special dividends.

    Premier is still under the influence of founder Solomon Lew, renowned for his retail savvy and ability to generate solid returns for shareholders, often through a shrewd capital management style.

    Valuation comparison

    Here’s how some of the standout numbers stack up:

    Metric Harvey Norman Premier Investments
    Market cap $5.15 billion $1.98 billion
    P/E ratio 9.80 15.38
    Dividend yield 6.63% 7.67%
    Dividend per share (2026) $0.26 $1.31
    Earnings per share 0.424 0.902
    Franking 100% 100%

    Note: Both companies are fully franked, which is a major plus for income-focused Aussie investors. Premier’s P/E is higher compared to Harvey Norman, which could reflect its recent strategic reset and growth bets, but the sectors (big-box retail vs. specialist brands) mean caution is warranted on a like-for-like valuation call.

    Recent share price momentum

    Comparing recent share price performance up to12 October 2026:

    • Harvey Norman closed at $4.13, down 0.48% on the day, with its year-to-date return sitting at -36.2%. That’s a hefty slide, suggesting headwinds for the traditional retail model or one-off impacts this year.
    • Premier Investments closed at $12.43, up 0.4% on the day, with a year-to-date return of -7.0%. While negative, it’s nowhere near as steep as Harvey Norman’s decline.

    Which is the better buy?

    If I had to plant my flag on the better founder-led buy for 2026, I’d lean toward Premier Investments. Premier’s portfolio is leaner and much more focused post-demerger, with two high-margin, brand-driven businesses and international ambitions. Its negative YTD return is milder, the dividend yield is higher at 7.67%, and management keeps surprising with special dividends—a sign of strong cash flows and nimble capital management.

    Harvey Norman, by contrast, looks like it’s facing tougher retail conditions, as shown by its much steeper share price fall this year. Yes, its P/E ratio is lower, and it still throws off reliable dividends, but for genuine growth or brand-driven differentiation, Premier now sets itself apart.

    Both companies have storied founders still in the driver’s seat, but for me, Premier’s current trajectory and sharper focus make it the more compelling prospect right now. If dividend income and upside optionality matter to you, my pick would be Premier Investments.

    The post Harvey Norman vs Premier Investments: Which founder-led stock is the better buy in 2026? appeared first on The Motley Fool Australia.

    More reading

    Motley Fool contributor Laura Stewart has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has positions in and has recommended Harvey Norman. The Motley Fool Australia has recommended Premier Investments. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips. This article was prepared with the assistance of Large Language Model (LLM) tools for the initial draft. Any content assisted by AI is subject to our robust human-in-the-loop quality control framework, involving thorough review, substantial editing, and fact-checking by our experienced writers and editors holding appropriate credentials. The Motley Fool Australia stands behind the work of our editorial team and takes ultimate responsibility for the content published by The Motley Fool Australia.

  • 3 fantastic ASX ETFs for buy and hold investors

    ETF written in white on a multi coloured background.

    Buying and holding investments for the long term can be a great way to build wealth.

    But choosing what to own is important. Ideally, you want exposure to businesses and industries that have plenty of room to grow over the next decade and beyond.

    With that in mind, here are three ASX exchange traded funds (ETFs) that could be worth considering.

    Betashares Global Cybersecurity ETF (ASX: HACK)

    The first ETF I would look at is the Betashares Global Cybersecurity ETF.

    I think cybersecurity is an industry with a very promising long-term outlook.

    Just consider how much businesses have come to depend on technology. From banking and healthcare to retail and manufacturing, enormous amounts of valuable information are now stored and exchanged digitally.

    And as artificial intelligence (AI) becomes more widely used, keeping systems and information secure could become even more important.

    This creates opportunities for companies developing cybersecurity software and services.

    The Betashares Global Cybersecurity ETF provides exposure to a portfolio of these businesses, including companies involved in cloud security, network protection, and threat detection.

    I believe spending on cybersecurity will continue growing over the long term, which bodes well for its holdings.

    Global X FANG+ ETF (ASX: FANG)

    Another ASX ETF that could suit buy and hold investors is the Global X FANG+ ETF.

    This fund takes a concentrated approach to investing in some of the world’s biggest technology and growth companies.

    Its portfolio contains just 10 stocks, giving investors exposure to businesses operating in areas such as AI, cloud computing, ecommerce, and digital advertising.

    What I like about this fund is that many of these companies have already established dominant positions in their respective markets.

    They also have significant financial resources to keep investing in new products and technologies, which could help them remain leaders for years to come.

    Of course, holding just 10 companies makes this a higher-risk investment than a broadly diversified ETF.

    But for investors comfortable with that concentration, the Global X FANG+ ETF could offer substantial long-term growth potential.

    Betashares Asia Technology Tigers ETF (ASX: ASIA)

    A final ASX ETF to consider is the Betashares Asia Technology Tigers ETF.

    While US technology companies tend to dominate the headlines, some of the world’s most important technology businesses are based in Asia.

    This fund provides exposure to leading companies across markets including Taiwan, South Korea, and China.

    These businesses operate in areas such as semiconductor manufacturing, memory chips, ecommerce, and digital services.

    I particularly like the region’s importance to the global technology industry. The demand for more powerful computers, smartphones, data centres, and AI systems creates significant opportunities for Asian technology leaders.

    There is also considerable potential for digital services to grow as consumer spending and technology adoption increase across the region.

    For long-term investors looking beyond Wall Street, the Betashares Asia Technology Tigers ETF could be worth a closer look.

    The post 3 fantastic ASX ETFs for buy and hold investors appeared first on The Motley Fool Australia.

    More reading

    Motley Fool contributor James Mickleboro has positions in Betashares Capital – Asia Technology Tigers Etf. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

  • Santos share price jumps to fresh multi-year high: Here’s what brokers tip next

    Smiling oil worker in front of a pumpjack.

    The Santos Ltd (ASX: STO) share price has jumped higher in Wednesday afternoon trade.

    At the time of writing, the shares are up around 2% for the day, at a 12-year high of $9.04 a piece.

    Today’s increase follows four consecutive days of share price gains. The shares are now up around 6% over the past week alone, and have rallied 47% for the year to date.

    What has driven such strong share price gains for Santos this year?

    ASX energy shares have flown higher in 2026 as ongoing geopolitical tensions in the Middle East push oil prices close to record highs.

    Continued disruptions to the movement of oil out of the region pushed global oil prices above US$110 a barrel earlier this year, and after a brief drop around July, renewed conflict has seen oil prices surge again in October.

    Santos directly benefits from high oil prices because it lifts both its revenue and profit margin.

    The share price rally has also been supported by Santos’ strong half-year FY26 results announcement in August.

    The major ASX oil and gas giant reported a 2% year-on-year increase in sales revenue and a 1.7% increase in production volumes. The company also generated free cash flow from operations, driven by strong base business performance.

    Why is the share price spiking again this week?

    There isn’t any company specific price-sensitive news this week to explain the latest Santos share price rally.

    The latest increase is mostly likely a result of another strong rebound in oil prices this week.

    Trading Economics data shows that crude oil climbed above US$95 per barrel today, marking its fifth consecutive session of gains. Escalating conflict between Iran and Saudi Arabia this week has caused even more oil supply disruptions and tankers transiting the Strait of Hormuz are being targeted.

    Crude oil prices are now 63% higher than just 12 months ago.

    Are the shares a buy, sell, or hold?

    The data on Market Index was updated just yesterday, and it still shows that even after the latest rally, brokers are still very positive on Santos shares.

    All brokers have a strong buy rating. Although the average target price of $9.04 is exactly flat on where the shares are trading at the time of writing.

    The data on TradingView shows a little more insight. The majority (14 out of 17) of analysts have a buy/strong buy rating on the shares. But the average $9.24 target price implies around a 2% upside ahead, at the time of writing.

    But the range between the minimum and maximum is huge. Some think the shares have the potential to jump another 22% to $11 over the next 12 months. But others think the Santos share price could sink 22% to $7.07.

    My view on the Santos share price

    Oil price volatility aside, I think Santos still presents great growth potential over the next 12 months. 

    The oil and gas major is in the process of transitioning from a period of heavy capital expenditure to active production. It is heavily reliant on two massive multi-billion dollar developments, including its Barossa LNG Project in the Northern Territory and its Pikka Phase 1 Project in Alaska.

    Continuous production at Pikka commenced in June and it is fast progressing to full production. Just last month, Santos announced that it had successfully started seawater injection at its Nanushuk Drillsite-B (NDB) within the project.

    Santos expects its second-half FY26 production to be 20% to 30% higher than the first half, and the ramp-up production at Pikka could certainly help that goal be achieved (or even exceeded).

    The post Santos share price jumps to fresh multi-year high: Here's what brokers tip next appeared first on The Motley Fool Australia.

    More reading

    Motley Fool contributor Samantha Menzies has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

  • Financial statement inaccuracy

  • PFE | Pfizer and German partner BioNTech SE said Tuesday they’ve begun delivering doses of their coronavirus vaccine to US candidates with trials in Germany already underway.

  • PFE | Pfizer and German Parker BioNTech SE have begun delivering doses of their coronavirus vaccine for human testing US, trials in Germany already underway.

  • The performance outlook of tech companies.